Tumor vaccine workshop
Executive Summary
FDA will hold a public workshop on clinical development of tumor vaccines on Dec. 10-11. Topics to be discussed during the workshop include regulatory considerations, characteristics of dendritic cells, current methods for characterization of autologous and allogeneic whole cell tumor vaccines, preclinical strategies and biological assessments in early clinical trials. The workshop will be held at the Masur Auditorium on the National Institutes of Health campus in Bethesda, Md. The meeting begins at 7:30 a.m. on Dec. 10 and at 8 a.m. on Dec. 11